CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, USP MOUTHWASH

Страна: Канада

мова: англійська

Джерело: Health Canada

Активний інгредієнт:

CHLORHEXIDINE GLUCONATE

Доступна з:

SAGE PRODUCTS LLC

Код атс:

A01AB03

ІПН (Міжнародна Ім'я):

CHLORHEXIDINE

Дозування:

0.12%

Фармацевтична форма:

MOUTHWASH

Склад:

CHLORHEXIDINE GLUCONATE 0.12%

Адміністрація маршрут:

BUCCAL

Одиниць в упаковці:

15ML/473ML

Тип рецепту:

Prescription

Терапевтична области:

MISCELLANEOUS ANTI-INFECTIVES

Огляд продуктів:

Active ingredient group (AIG) number: 0107629007; AHFS:

Статус Авторизація:

CANCELLED POST MARKET

Дата Авторизація:

2022-04-22

Характеристики продукта

_ _
_ _
_Page 1 of 19_
PRODUCT MONOGRAPH
CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, USP
Chlorhexidine Gluconate 0.12% Oral Rinse
Liquid, 0.12% Chlorhexidine Gluconate
Antigingivital Oral Rinse
Sage Product LLC
3909 Three Oaks Road
Cary, IL 60013
USA
Date of Preparation:
February 17, 2015
Submission Control No: 180308
_ _
_ _
_Page 2 of 19_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................3
WARNINGS AND PRECAUTIONS
..................................................................................4
ADVERSE REACTIONS
....................................................................................................6
DOSAGE AND ADMINISTRATION
................................................................................6
OVERDOSAGE
..................................................................................................................7
ACTION AND CLINICAL PHARMACOLOGY
..............................................................8
STORAGE AND STABILITY
............................................................................................9
SPECIAL HANDLING INSTRUCTIONS
.........................................................................9
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................10
PART II: SCIENTIFIC INFORMATION
...............................................................................11
PHARMACEUTICAL INFORMATION
..........................................................................11
CLINICAL TRIALS
..........................................................................................................12
DETAILED PHARMACOLOGY
.........................